ChronoScale Holdings (CHRN) Non Operating Interest Expenses (2012 - 2026)
ChronoScale Holdings' (CHRN) quarterly Non Operating Interest Expenses came in at $143000.0 in Q1 2026, up 98.61% year-over-year from $72000.0 in Q1 2025, and down 7.74% quarter-over-quarter from $155000.0 in Q4 2025.
Analysis
ChronoScale Holdings (CHRN) Non Operating Interest Expenses (2012 - 2026) Analysis & Trends
ChronoScale Holdings (CHRN) has reported Non Operating Interest Expenses for 13 consecutive years, with $143000.0 the latest figure, recorded in Q1 2026.
- On a quarterly basis, Non Operating Interest Expenses rose 98.61% year-over-year to $143000.0 in Q1 2026; TTM through Mar 2026 was $388000.0, a 36.62% increase from a year earlier, with the FY2025 full-year figure at $309000.0, up 14.87% from the prior year.
- Non Operating Interest Expenses was $143000.0 for Q1 2026 at ChronoScale Holdings, down from $155000.0 in the prior quarter.
- Over five years, Non Operating Interest Expenses peaked at $155000.0 in Q4 2025 and troughed at $18000.0 in Q3 2025.
- A 5-year average of $69750.0 and a median of $65000.0 in 2022 frame the typical range for Non Operating Interest Expenses.
- Across the five-year window, Non Operating Interest Expenses jumped 314.81% in 2023 and tumbled 77.22% in 2025, its largest moves.
- Over 5 years, Non Operating Interest Expenses stood at $66000.0 in 2022, then changed by 0.0% to $66000.0 in 2023, then dropped by 10.61% to $59000.0 in 2024, then soared by 162.71% to $155000.0 in 2025, then decreased by 7.74% to $143000.0 in 2026.
- The last three Non Operating Interest Expenses figures came in at $143000.0 (Q1 2026), $155000.0 (Q4 2025), and $18000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 15.80 Mn |
| 10 | ChronoScale Holdings | 2.52 Bn | 2.51 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 143,000.00 |
| Dec 31, 2025 | 155,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Dec 31, 2024 | 59,000.00 |
| Sep 30, 2024 | 79,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Mar 31, 2024 | 57,000.00 |
| Dec 31, 2023 | 66,000.00 |
| Sep 30, 2023 | 64,000.00 |
| Jun 30, 2023 | 61,000.00 |
| Mar 31, 2023 | 112,000.00 |
| Dec 31, 2022 | 66,000.00 |
| Sep 30, 2022 | 34,000.00 |
| Jun 30, 2022 | 29,000.00 |
| Mar 31, 2022 | 27,000.00 |
| Dec 31, 2021 | 36,000.00 |
| Sep 30, 2021 | 24,000.00 |
| Jun 30, 2021 | 27,000.00 |
| Mar 31, 2021 | 26,000.00 |